Literature DB >> 16981844

Systematic screening for polymorphisms in the CYP3A4 gene in the Chinese population.

Jing Du1, Qinghe Xing, Lingyun Xu, Mingsheng Xu, Anli Shu, Yongyong Shi, Lan Yu, Aiping Zhang, Lei Wang, Hongsheng Wang, Xingwang Li, Guoyin Feng, Lin He.   

Abstract

OBJECTIVES: Cytochrome P450 3A4 (CYP3A4) is a major CYP enzyme in the liver and intestine. It is involved in the metabolism of over 50% of all drugs currently in use. The present study was designed to determine the genetic basis of CYP3A4 variability.
METHODS: Single nucleotide polymorphism (SNP) analysis of the CYP3A4 gene was performed on 60 healthy Chinese subjects consisting of 20 Han, 30 She and ten Dong subjects, using direct sequencing. Linkage disequilibrium, haplotype inference and Hardy-Weinberg equilibrium were also determined for these samples.
RESULTS: A total of 20 SNPs were found in the CYP3A4 gene, including 11 known SNPs and nine novel SNPs. The known SNPs detected in our study were CYP3A4*1B, CYP3A4*1G, CYP3A4*10, CYP3A4*13, CYP3A4*14, CYP3A4*15, CYP3A4*17, CYP3A4*18, rs3091339, rs3091430 and rs28371761, and the novel SNPs were -658 A-->C, G27A (E10K), T48A, G14284A (G167D), A15623G (N191D), C15635A (L196I), T15656C (F203L), G14199A (intron 5) and C15566T (intron 6). The allelic frequencies found in our sample varied from 1-37%. The novel SNPs detected in the CYP3A4 gene suggest that the Chinese population has different patterns of allele frequency compared with other populations.
CONCLUSION: Several SNPs were detected in the CYP3A4 gene. The study of genetic variants in CYP3A4 may have an important significance for the understanding of genotype and phenotype relationships.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16981844     DOI: 10.2217/14622416.7.6.831

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  22 in total

1.  Pharmacokinetics and tolerability of single and multiple doses of ticagrelor in healthy Chinese subjects: an open-label, sequential, two-cohort, single-centre study.

Authors:  Haiyan Li; Kathleen Butler; Li Yang; Zhenghua Yang; Renli Teng
Journal:  Clin Drug Investig       Date:  2012-02-01       Impact factor: 2.859

2.  Correlations between CYP3A4 polymorphism and susceptibility to breast cancer in Chinese Han population.

Authors:  Xu Liu; Xi Huang; Shanshan Zhang; Fanglin Niu; Yongri Ouyang; Zhexing Shou; Jikui Liu
Journal:  Int J Clin Oncol       Date:  2018-09-14       Impact factor: 3.402

3.  Effects of CYP2C19 and CYP3A5 genetic polymorphisms on the pharmacokinetics of cilostazol and its active metabolites.

Authors:  Hye-In Lee; Ji-Young Byeon; Young-Hoon Kim; Choong-Min Lee; Chang-Ik Choi; Choon-Gon Jang; Jung-Woo Bae; Yun Jeong Lee; Seok-Yong Lee
Journal:  Eur J Clin Pharmacol       Date:  2018-07-24       Impact factor: 2.953

4.  Pharmacodynamics, pharmacokinetics, and safety of ticagrelor in Chinese patients with stable coronary artery disease.

Authors:  Haiyan Li; Jingchuan Guo; Glenn F Carlson; Renli Teng
Journal:  Br J Clin Pharmacol       Date:  2016-06-09       Impact factor: 4.335

5.  Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians.

Authors:  Fabiana B Kohlrausch; Ángel Carracedo; Mara H Hutz
Journal:  Mol Biol Rep       Date:  2014-01-18       Impact factor: 2.316

6.  Role of pharmacogenetics on adjuvant chemotherapy-induced neutropenia in Chinese breast cancer patients.

Authors:  Nelson L S Tang; Chen Di Liao; Xingyan Wang; Frankie K F Mo; Vicky T C Chan; Rita Ng; Elizabeth Pang; Joyce J S Suen; Jean Woo; Winnie Yeo
Journal:  J Cancer Res Clin Oncol       Date:  2012-11-10       Impact factor: 4.553

7.  CYP3A4*1G genetic polymorphism influences CYP3A activity and response to fentanyl in Chinese gynecologic patients.

Authors:  Wei Zhang; Yan-Zi Chang; Quan-Cheng Kan; Li-Rong Zhang; Zhi-Song Li; Hui Lu; Zhong-Yu Wang; Qin-Jun Chu; Jie Zhang
Journal:  Eur J Clin Pharmacol       Date:  2009-09-26       Impact factor: 2.953

8.  Associations of CYP3A4, NR1I2, CYP2C19 and P2RY12 polymorphisms with clopidogrel resistance in Chinese patients with ischemic stroke.

Authors:  Rui Liu; Zi-Yi Zhou; Yi-Bei Chen; Jia-Li Li; Wei-Bang Yu; Xin-Meng Chen; Min Zhao; Yuan-Qi Zhao; Ye-Feng Cai; Jing Jin; Min Huang
Journal:  Acta Pharmacol Sin       Date:  2016-05-02       Impact factor: 6.150

9.  Polymorphisms and phenotypic analysis of cytochrome P450 3A4 in the Uygur population in northwest China.

Authors:  Tianbo Jin; Hua Yang; Jiayi Zhang; Zulfiya Yunus; Qiang Sun; Tingting Geng; Chao Chen; Jie Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

10.  Incidence of genetic polymorphisms involved in lipid metabolism among Chinese patients with osteonecrosis of the femoral head.

Authors:  Wei He; Keda Li
Journal:  Acta Orthop       Date:  2009-06       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.